Organization | Age to initiate (years)¶ | Age to discontinue (years) | Recommended screening test and frequency | Post-hysterectomy (with cervix removed) for benign disease | HPV vaccination | |
In our practice, we use the following guidelines, in order of preference: | ||||||
USPSTF (2018) | 21 | 65Δ | Age 21 to 29 years Pap test every 3 years | Age ≥30 years One of these methods:
| Not indicated§ | Same recommendations as unvaccinated patients |
ACS (2020) | 25 | 65¥ | Age ≥25 years One of these methods:
| Not indicated‡ | Same recommendations as unvaccinated patients | |
Other expert group recommendations: | ||||||
Age 21 to 29 years | Age ≥30 years | |||||
ACOG (2016) | 21 | 65Δ | One of these methods:
| One of these methods:
| Not indicated§ | Same recommendations as unvaccinated patients |
ACP (2015) | 21 | 65Δ | Pap test every 3 years | One of these methods:
| Not indicated§ | N/A |
ASCCP/SGO (2015 interim guidelines) | 21 | N/A | Can consider primary HPV testing◊ every 3 years for patients age ≥25 | Can consider primary HPV testing◊ every 3 years | N/A | N/A |
ACS/ASCCP/ASCP (2012) | 21¶ | 65† | Pap test every 3 years (preferred) | One of these methods:
| Not indicated** | Same recommendations as unvaccinated patients |